$2.92
-0.20-6.41%
At close: -
$2.92
0.000.00%
After Hours: 5:27 PM EDT
Comments
Loading...
Terns Pharma Insider Trading Activity | NASDAQ:TERN | Benzinga
Track the latest Terns Pharma insider trading activity. Stay informed on recent buys, sells, and market impact for Terns Pharma stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are Terns Pharmaceuticals Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 3, 2025, Melita Sun Jung, the company's CHIEF BUSINESS OFFICER purchased 2.25K shares for $5.11 each.
- On February 3, 2025, Amy L Burroughs, the company's CHIEF EXECUTIVE OFFICER purchased 510 shares for $5.11 each.
- On January 6, 2025, Emil Kuriakose, the company's CHIEF MEDICAL OFFICER sold 4.48K shares for $5.71 each.
Ownership Statistics for Terns Pharmaceuticals Inc
Shares Outstanding
87.298M
Insider Shares Owned
702.977K
Insider Percentage Owned
0.83%
Institutional Shares Held
23.426M
Institutional Percentage Held
27.6%
| Feb 03, 2025 | Melita Sun Jung | CHIEF BUSINESS OFFICER | 2.25K | $5.11 | $11.50K | BUY | ∞ | 2.25K | Nov 30 | View |
| Feb 03, 2025 | Amy L Burroughs | CHIEF EXECUTIVE OFFICER | 510.00 | $5.11 | $2.61K | BUY | 2.67% | 19.61K | Nov 30 | View |
| Jan 06, 2025 | Emil Kuriakose | CHIEF MEDICAL OFFICER | -4.48K | $5.71 | -$25.61K | SELL | -7.63% | 54.27K | Jan 02 | View |
| Jan 06, 2025 | Mark J Vignola | CHIEF FINANCIAL OFFICER | -17.19K | $5.76 | -$99.02K | SELL | -18.69% | 74.75K | Jan 02 - Jan 06 | View |
| Jan 06, 2025 | Jill M Quigley | — | -15.00K | $5.76 | -$86.46K | SELL | -100.00% | 0.00 | Jan 02 - Jan 06 | View |
| Dec 09, 2024 | Amy L Burroughs | CHIEF EXECUTIVE OFFICER | 15.45K | $7.15 | $110.47K | BUY | 423.40% | 19.10K | Dec 05 | View |
| Sep 17, 2024 | Hongbo Lu By: Hongbo Lu | DIRECTOR | 476.19K | $10.50 | $5.00M | BUY | ∞ | 476.19K | Sep 12 | View |
| Sep 12, 2024 | Mark J Vignola | CHIEF FINANCIAL OFFICER | 0.00 | $8.18 | -$56.40K | SELL-OPTIONS | 0.00% | 91.94K | Sep 10 | View |
| Sep 11, 2024 | Jill M Quigley | — | 0.00 | $5.91 | -$140.98K | SELL-OPTIONS | 0.00% | 15.00K | Sep 09 | View |
| Aug 05, 2024 | Jill M Quigley | — | -15.00K | $7.57 | -$113.58K | SELL | -50.00% | 15.00K | Aug 01 - Aug 02 | View |
| Jul 17, 2024 | Carl L Gordon | DIRECTOR | -56.16K | $10.00 | -$561.64K | SELL | -6.92% | 755.63K | Jul 15 - Jul 16 | View |
| Jul 17, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III LtdOrbiMed Genesis GP LLC | DIRECTOR | -56.16K | $10.00 | -$561.64K | SELL | -6.92% | 755.63K | Jul 15 - Jul 16 | View |
| Jul 17, 2024 | Jill M Quigley | — | 0.00 | $5.91 | -$120.79K | SELL-OPTIONS | 0.00% | 30.00K | Jul 15 - Jul 16 | View |
| Jun 04, 2024 | Seokho Bryan Yoon | COO AND GENERAL COUNSEL | 4.79K | $4.44 | $21.27K | BUY | 5.50% | 91.94K | May 31 | View |
| Jun 04, 2024 | Mark J Vignola | CHIEF FINANCIAL OFFICER | 4.79K | $4.44 | $21.27K | BUY | 5.50% | 91.94K | May 31 | View |
| Apr 03, 2024 | Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | 10% OWNER | -420.66K | $6.65 | -$2.80M | SELL | -61.03% | 268.57K | Apr 01 - Apr 03 | View |
| Dec 04, 2023 | Seokho Bryan Yoon | COO AND GENERAL COUNSEL | 743.00 | $3.78 | $2.81K | BUY | 4.21% | 18.40K | Nov 30 | View |
| Dec 04, 2023 | Mark J Vignola | CHIEF FINANCIAL OFFICER | 743.00 | $3.78 | $2.81K | BUY | 4.21% | 18.40K | Nov 30 | View |
| Jun 02, 2023 | Mark J Vignola | CHIEF FINANCIAL OFFICER | 10.00K | $1.41 | $14.10K | BUY | 130.53% | 17.66K | May 31 | View |
| Jun 02, 2023 | Seokho Bryan Yoon | COO AND GENERAL COUNSEL | 10.00K | $1.41 | $14.10K | BUY | 130.53% | 17.66K | May 31 | View |
| Jun 02, 2023 | Senthil Sundaram | CHIEF EXECUTIVE OFFICER | 2.11K | $1.41 | $2.98K | BUY | 27.56% | 9.77K | May 31 | View |
| Feb 03, 2023 | Seokho Bryan Yoon | COO AND GENERAL COUNSEL | 3.00 | $1.41 | $4.23 | BUY | 0.04% | 7.66K | Nov 30 | View |
| Feb 03, 2023 | Mark J Vignola | CHIEF FINANCIAL OFFICER | 3.00 | $1.41 | $4.23 | BUY | 0.04% | 7.66K | Nov 30 | View |
| Feb 03, 2023 | Senthil Sundaram | CHIEF EXECUTIVE OFFICER | 3.00 | $1.41 | $4.23 | BUY | 0.04% | 7.66K | Nov 30 | View |
| Dec 28, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III LtdOrbiMed Genesis GP LLC | DIRECTOR | 137.93K | $7.25 | $1000.00K | BUY | 2.50% | 5.65M | Dec 23 | View |
| Dec 28, 2022 | Carl L Gordon | DIRECTOR | 137.93K | $7.25 | $1000.00K | BUY | 2.50% | 5.65M | Dec 23 | View |
| Dec 23, 2022 | Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | 10% OWNER | 758.62K | $7.25 | $5.50M | BUY | 19.64% | 4.62M | Dec 23 | View |
| Dec 23, 2022 | Hongbo Lu | — | 758.62K | $7.25 | $5.50M | BUY | 21.18% | 4.34M | Dec 23 | View |
| Nov 28, 2022 | LAV Biosciences Fund V LPHopewell Resources Holdings LtdLAV Aqua LtdOriental Spring Venture Ltd | 10% OWNER | -1.50M | $5.50 | -$8.25M | SELL | -45.23% | 1.82M | Nov 23 | View |
| Sep 08, 2022 | Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | 10% OWNER | 600.00K | $3.60 | $2.16M | BUY | 18.39% | 3.86M | Sep 07 | View |
| Sep 08, 2022 | Hongbo Lu | — | 600.00K | $3.60 | $2.16M | BUY | 20.12% | 3.58M | Sep 07 | View |
| Aug 18, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III LtdOrbiMed Genesis GP LLC | DIRECTOR | 3.69M | $2.42 | $8.93M | BUY | ∞ | 762.40K | Aug 16 | View |
| Aug 18, 2022 | Carl L Gordon | DIRECTOR | 3.69M | $2.42 | $8.93M | BUY | ∞ | 762.40K | Aug 16 | View |
| Aug 16, 2022 | Vivo Opportunity LLCVivo Opportunity Fund Holdings LPVivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LP | 10% OWNER | 2.62M | $2.66 | $6.98M | BUY | 410.95% | 3.26M | Aug 12 - Aug 16 | View |
| Aug 16, 2022 | Hongbo Lu | — | 2.62M | $2.66 | $6.98M | BUY | 734.35% | 2.98M | Aug 12 - Aug 16 | View |
| Jun 08, 2022 | Seokho Bryan Yoon | COO AND GENERAL COUNSEL | 7.66K | $1.47 | $11.25K | BUY | ∞ | 7.66K | May 31 | View |
| Jun 08, 2022 | Mark J Vignola | CHIEF FINANCIAL OFFICER | 7.66K | $1.47 | $11.25K | BUY | ∞ | 7.66K | May 31 | View |
| Jun 08, 2022 | Senthil Sundaram | CHIEF EXECUTIVE OFFICER | 7.66K | $1.47 | $11.25K | BUY | ∞ | 7.66K | May 31 | View |
| Feb 09, 2021 | Carl Gordon | DIRECTOR | 3.79M | $17.00 | $8.07M | BUY | ∞ | 2.27M | Feb 09 | View |
| Feb 09, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VII LLCOrbiMed Asia GP III LPOrbiMed Advisors III Ltd | DIRECTOR | 3.79M | $17.00 | $8.07M | BUY | ∞ | 2.27M | Feb 09 | View |
| Feb 09, 2021 | Vivo Capital VIII LLCVivo Capital Fund VIII LPVivo Capital Surplus Fund VIII LPVivo Opportunity LLCVivo Opportunity Fund LP | 10% OWNER | 2.68M | $17.00 | $8.07M | BUY | ∞ | 357.35K | Feb 09 | View |
| Feb 09, 2021 | James FlynnDEERFIELD MANAGEMENT COMPANY LP SERIES CDEERFIELD PARTNERS LPDeerfield Mgmt LP | 10% OWNER | 2.38M | $17.00 | $11.30M | BUY | ∞ | 2.38M | Feb 09 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.